Live Chat
Select Page
Yashoda Hospitals > Doctors > Oncology > Dr. Bala Raju Kotla
Dr. Bala Raju Kotla

Dr. Bala Raju Kotla

MBBS, DNB (General Surgery), DrNB (Surgical Oncology), FIAGES

Department : Surgical Oncology, Oncology
Exp: 11 yrs
Designation: Consultant Surgical Oncologist
Minimal Invasive Surgeon
Languages: Telugu, Hindi, English
Med Reg No: APMC/FMR/74566

Day time OPD:
MON - SAT : 09:00 AM - 4:00 PM

Location: Malakpet
Book An Appointment Book Online Consultation
Download Profile

About the Doctor

Dr. Bala Raju Kotla is a Consultant Surgical Oncologist & Minimal Invasive Surgeon at Yashoda Hopsitals, Malakpet.

Educational Qualifications

  • 2018: DrNB Surgical Oncology, Yashoda Super Speciality Hospital, Somajiguda, Hyderabad
  • 2013: DNB General Surgery, St. Teresa’s General Hospital, Hyderabad
  • 2006: MBBS, Kamineni Institute of Medical Sciences, Narketpally

Experience

  • 2021-Present: Consultant Surgical Oncologist & Minimal Invasive Surgeon, Yashoda Hospitals, Malakpet
  • 2016-2018: Senior Resident, Department of Urology, ESIC Super Speciality Hospital, Sanathnagar

Services offered

  • Head & Neck Cancer Surgeries
  • Thyroid, Breast, Lung, and Gastrointestinal Cancer Surgeries
  • Gynecological Cancer Surgeries
  • Laparoscopic and Robotic Surgeries

Special Interest and Expertise

  • Head and Neck, Breast Oncoplasty
  • Robotic Surgeries
Download Profile
  • Won Best Poster award at CIDSCON, Nagpur, 2017
  • Won Best Poster award at APICON, Mumbai, 2017
  • Won 1st prize at a quiz competition at a national level at APICON, Mumbai, 2017
  • Received scholarship grants for participating in various international meetings such as the Leukaemia, Lymphoma and Myeloma conference, New York, October 2021 (Scholarship Award); and the (virtual) European Society of Medical Oncology, 2021 (International Cancer Foundation Grant). (Virtual) Society of Haematologic Oncology, Texas, USA, Sept 2021 (Young Investigator Program travel grant) European Haematologic Association, Annual meet, July 2021 (virtual) HOPE Asia, Sri Lanka, Asia, 2020
  • Qualified in ESMO exam, September 2021
  • Recipient of a YIP (Young Investigator Program) travel grant from SOHO, Texas, USA, in 2022 for a poster on myeloma in September 2022.
  • Recipient of a travel grant to ESMO Asia, Singapore, Nov 2022, on behalf of ISMPO.
  • Honours in Anatomy, Biochemistry, Pathology, Microbiology, Ophthalmology, ENT, Obstetrics & Gynaecology during undergraduate studies.
  • Received palliative training course from BMJ publications
  • Association of Surgeons of India (ASI)
  • Indian Association of Surgical Oncologists (IASO)
  • Indian Association of Gastrointestinal Endoscopic Surgeons (IAGES)
  • Association of Robotic and Innovative Surgeons (ARIS)
  • Nivalika R, Musugu JM, Reddy LR, Madhuvijay P, Ingle A. A Rare Case of Metaplastic Carcinoma of the Axillary Tail with Coexisting Extrapulmonary Liver Tuberculosis Mimicking a Solitary Liver Metastasis: A Diagnostic and Therapeutic Challenge. Indian Journal of Gynaecologic Oncology. 2025 Dec;23(4):131.
  • Reddy, L.R., Kumar, L., Malik, P.S., Sahoo, R.K., Prasad, C. and Gupta, R., 2025. Management of Relapsed/Refractory Myeloma in Resource Constrained Setting: Median age (years) Age (Years) Immunoglobulin subtype Hb (G/dL) Serum creatinineeGFR mL/minute Serum albumin (g/dL) Serum LDH, platelet counts Circulating plasma cells, cytogenetics, hypercalcemia, co-morbidities, diabetes, hypertension Hypothyroidism, F/H of malignancy. Clinical Lymphoma, Myeloma and Leukaemia.
  • Hardy N, Vegivinti CT, Mehta M, Thurnham J, Mebane A, Pederson JM, Tarchand R, Shivakumar J, Olaniran P, Gadodia R, Ganguly A. Mortality of COVID-19 in patients with haematological malignancies versus solid tumours: a systematic literature review and meta-analysis. Clinical and Experimental Medicine. 2023 Oct;23(6):1945-59.
  • Tansir G, Rastogi S, Dubasi SK, Chitikela S, Reddy LR, Barwad A, Goyal A. Lessons learnt from the clinico-genomic profiling of families with Li Fraumeni syndrome at a tertiary care centre in North India. ecancermedicalscience. 2023 May 11;17:1550.
  • Sharma A, Reddy R, Pramanik R, Sahoo RK, Kaushal S, Haresh KP, Kumar S, Kumar L, Sharma A, Batra A. Primary mediastinal germ cell tumours (PMGCT): A real-world analysis from a tertiary cancer care centre in India. Cancer Investigation. 2023 May 28;41(5):467-73.
  • Reddy LR, Kumar L, Veligapudi RM, Konda S. MM-252 A Retrospective Review of Relapsed Multiple Myeloma Post Autologous Stem Cell Transplant: Data From an Indian Tertiary Cancer Centre. Clinical Lymphoma, Myeloma and Leukaemia. 2022 Oct 1;22:S416. (SOHO Texas 2022)
  • Reddy R, Velagapudi RM, Chitikela SD, Barwad A, Shrivastava S, Dhamija E, Shamim SA, Tripathy S, Pandey R, and Rastogi S. Indian experience with immunotherapy in sarcoma and gastrointestinal stromal tumours: a retrospective study. Future Science OA. 2022 Jun 1;8(5):FSO795.
  • Lavu RR, Kumar L, Konda S, Velagapudi RM. PB2010: RETROSPECTIVE STUDY OF RELAPSED/REFRACTORY MYELOMA PATIENTS FROM AN INDIAN TERTIARY CENTRE: RESPONSE MATTERS!!. HemaSphere. 2022 Jun 1;6:1881-2. (EHA. Vienna, 2022 )
  • Reddy LR, Rasheed AA, Rastogi S. The evolving role of precision medicine in the management of advanced sarcomas – a mini review. International Journal of Molecular and Immuno Oncology. 2021 Sep 27;6(3):122-31.
  • Poster: MM-257: It’s the Response That Matters: Real-World Data of Multiple Myeloma Patients Treated without Upfront Stem Cell Transplant Lavu, Rohit Reddy et al. Clinical Lymphoma, Myeloma and Leukemia, Volume 21, S255 – Presented at SOHO, Texas, 2021
  • Seminomatous and non-seminomatous mediastinal germ cell tumours (MGCT): A real-world analysis from two tertiary care centres in India. Aparna Sharma, Bivas Biswas, Rohit Reddy, Robin Thumbudorai, Sandip Ganguly, Deepak Dabkara, Raja Pramanik, Sunil Kumar, Ranjit Kumar Sahoo, Atul Sharma, Lalit Kumar, and Atul Batra. Journal of Clinical Oncology 2021 39:15_suppl, e18726-e18726-e abstract ASCO 2021
  • Oral Presentation No. – O-6, titled “Indian experience with immunotherapy in sarcoma and GIST: A retrospective study" at IMSOS, India, 2021.
  • Verma S, Reddy R, Chandrashekhara SH, Shamim SA, Tripathy S, Rastogi S. Avapritinib in Advanced Gastrointestinal Stromal Tumour: Case Series and Review of the Literature from a Tertiary Care Centre in India. Future Science OA. 2020 Dec(0):FSO676.
  • Varma M, Reddy LR, Vidyasagar S, Holla A, Bhat NK. Risk Factors for Carbapenem-Resistant Enterobacteriaceae in a Tertiary Hospital – A Case-Control Study. Indian Journal of Medical Specialities. 2018 Oct 1;9(4):178-83.
  • Weber SF, Bélard S, Rai S, Reddy R, Belurkar S, Saravu K. ImmuneThrombocytopenia Secondary to Tuberculosis: A Case and Review of Literature. The International Journal of Tuberculosis and Lung Disease. 2017 Apr 1;21(4):466-70.
  • Bhat N, Vidyasagar S, Reddy R, Holla A. Ranitidine-Induced Anaphylaxis. APIK Journal of Internal Medicine. 2016 Jul 1;4(3):36.

FAQ's

    Dr. Bala Raju Kotla holds the following qualifications: MBBS, DNB (General Surgery), DrNB (Surgical Oncology), FIAGES.

    Dr. Bala Raju Kotla is a Consultant Surgical Oncologist & Minimal Invasive Surgeon who specialises in Head & Neck Cancer Surgeries, Thyroid, Breast, Lung, and Gastrointestinal Cancer Surgeries, Gynecological Cancer Surgeries, and Laparoscopic and Robotic Surgeries, among others.

    Dr. Bala Raju Kotla practices at Yashoda Hospitals, Malakpet.

    You can schedule an appointment with Dr. Bala Raju Kotla for an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.

Book an appointment
in 2 minutes